Pre-clinical models of neurodevelopmental disorders: Focus on the cerebellum

Reviews in the Neurosciences

Volumn 25, Issue 2, 2014, Pages 177-194

  Shevelkin, Alexey V ^a,b   Ihenatu, Chinezimuzo ^a,c   Pletnikov, Mikhail V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

^c BROWN UNIVERSITY   (United States)

Author keywords

Animal model; Autism; Cerebellum; Purkinje cells; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; PROTEIN; SHANK3 PROTEIN; THYROID HORMONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ENGRAILED 2; TRANSCRIPTION FACTOR FOXP2; TUBERIN; UNCLASSIFIED DRUG; VALPROIC ACID;

AMYGDALOID NUCLEUS; ARTICLE; AUTISM; BEHAVIOR CHANGE; BIPOLAR DISORDER; BORNA DISEASE VIRUS; BRAIN REGION; BRAIN STEM; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CEREBELLUM DISEASE; DEPRESSION; DEVELOPMENTAL DISORDER; DISEASE EXACERBATION; DISEASE MODEL; ELEVATED T-MAZE TEST; GENETIC MODEL; GRANULE CELL; HISTOPATHOLOGY; HUMAN; HYPOTHALAMUS; HYPOTHYROIDISM; INFLUENZA; LEARNING; MEMORY; MENTAL DISEASE; MENTAL HEALTH; MYELINATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; ORBITAL CORTEX; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL BEHAVIOR; TUBEROUS SCLEROSIS;

ANIMALS; CEREBELLUM; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84901756919     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2013-0049     Document Type: Article

References (184)

1. Akaike, M. and Kato, N. (1997). Abnormal behavior, spatia learning impairment and neuropeptides caused by temporary neonatal hypothyroidism. In: Recent Research Development in Neuroendocrinology-Thyroid Hormone and Brain Maturation. C.E. Hendrich, ed. (Trivandrum: Research Signpost), pp. 39-48.
2. Akaike, M., Kato, N., Ohno, H., and Kobayashi, T. (1991). Hyperactivity and spatial maze learning impairment of adult rats with temporary neonatal hypothyroidism. Neurotoxicol. Teratol. 13, 317-322.
3. Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. (2001). Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 413, 732-738.
4. Amaral, D.G., Schumann, C.M., and Nordahl, C.W. (2008). Neuroanatomy of autism. Trends Neurosci. 31, 137-145.
5. Andreasen, N.C. and Pierson, R. (2008). The role of the cerebellum in schizophrenia. Biol. Psychiatry 64, 81-88.
6. Andreasen, N.C., O'Leary, D.S., Cizadlo, T., Arndt, S., Rezai, K., Ponto, L.L., Watkins, G.L., and Hichwa, R.D. (1996). Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc. Natl. Acad. Sci. USA 93, 9985-9990.
7. Andreasen, N.C., Paradiso, S., O'Leary, D.S. (1998). 'Cognitive dysmetria' as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr. Bull. 24, 203-218.
8. Arias, I., Sorlozano, A., Villegas, E., de Dios Luna, J., McKenney, K., Cervilla, J., Gutierrez, B., and Gutierrez, J. (2012). Infectious agents associated with schizophrenia: a meta-analysis. Schizophr. Res. 136, 128-136.
9. Arguello, P.A. and Gogos, J.A. (2012). Genetic and cognitive windows into circuit mechanisms of psychiatric disease. Trends Neurosci. 35, 3-13.
10. Austin, C.P., Ky, B., Ma, L., Morris, J.A., and Shughrue, P.J. (2003). DISC1 (Disrupted in Schizophrenia-1) is expressed in limbic regions of the primate brain. Neuroreport 14, 951-954.
11. Austin, C.P., Ky, B., Ma, L., Morris, J.A., and Shughrue, P.J. (2004). Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience 124, 3-10.
12. Bacon, C. and Rappold, G.A. (2012). The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders. Hum Genet. 131, 1687-1698.
13. Bartzokis, G. (2012). Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology 62, 2137-2153.
14. Beraki, S., Aronsson, F., Karlsson, H., Ogren, S.O., and Kristensson, K. (2005). Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol. Psychiatry 10, 299-308.
15. Beri, S., Tonna, N., Menozzi, G., Bonaglia, M.C., Sala, C., and Giorda, R. (2007). DNA methylation regulates tissue-specific expression of Shank3. J. Neurochem. 101, 1380-1391.
16. Blatt, G.J. (2005). GABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int. Rev. Neurobiol. 71, 167-178.
17. Boeckers, T.M., Bockmann, J., Kreutz, M.R., and Gundelfinger, E.D. (2002). ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J. Neurochem. 81, 903-910.
18. Boksa, P. (2010). Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain. Behav. Immun. 24, 881-897.
19. Bonaglia, M.C., Giorda, R., Mani, E., Aceti, G., Anderlid, B.M., Baroncini, A., Pramparo, T., and Zuffardi, O. (2006). Identification of a recurrent break point within the Shank3 gene in the 22p13.3 deletion syndrome. J. Med. Genet. 43, 822-828.
20. Bord, L., Wheeler, J., Paek, M., Saleh, M., Lyons-Warren, A., Ross, C.A., Sawamura, N., and Sawa, A. (2006). Primate disrupted-in-schizophrenia-1 (DISC1): high divergence of a gene for major mental illnesses in recent evolutionary history. Neurosci. Res. 56, 286-293.
21. Boukhtouche, F., Janmaat, S., Vodjdani, G., Gautheron, V., Mallet, J., Dusart, I., and Mariani, J. (2006). Retinoid-related orphan receptor α controls the early steps of purkinje cell dendritic differentiation. J. Neurosci. 26, 1531-1538.
22. Boyadjieva, N. and Varadinova, M. (2012). Epigenetics of psychoactive drugs. J. Pharm. Pharmacol. 64, 1349-1358.
23. Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D.L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A.M., Scattoni, M.L., et al. (2010). Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism 1, 15.
24. Brandon, N.J. and Sawa, A. (2011). Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 12, 707-722.
25. Brielmaier, J., Matteson, P.G., Silverman, J.L., Senerth, J.M., Kelly, S., Genestine, M., Millonig, J.H., DiCicco-Bloom, E., and Crawley, J.N. (2012). Autism-relevant social abnormalities and cognitive deficits in engrailed-2 knockout mice. PLoS One 7, e40914.
26. Brown, A.S. and Derkits, E.J. (2010). Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 167, 261-280.
27. Buffo, A. and Rossi, F. (2013). Origin, lineage and function of cerebellar glia. Prog. Neurobiol. 109, 42-63.
28. Burnet, P.W., Eastwood, S.L., Bristow, G.C., Godlewska, B.R., Sikka, P., Walker, M., and Harrison, P.J. (2008). D-amino acid oxidase activity and expression are increased in schizophrenia. Mol. Psychiatry 13, 658-660.
29. Burrows, E.L., McOmish, C.E., and Hannan, A.J. (2011). Gene-environment interactions and construct validity in preclinical models of psychiatric disorders. Prog. Neuro-Psych. 35, 1376-1382.
30. Buyske, S., Williams, T.A., Mars, A.E., Stenroos, E.S., Ming, S.X., Wang, R., Sreenath, M., Factura, M.F., Reddy, C., Lambert, G.H., et al. (2006). Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism. BMC Genet. 7, 8.
31. Camargo, L.M., Collura, V., Rain, J.C., Mizuguchi, K., Hermijakob, H., Kerrien, S., Bonnert, T.P., Whiting, P.J., and Brandon, N.J. (2007). Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12, 74-86.
32. Chaste, P. and Leboyer, M. (2012). Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin. Neurosci. 14, 281-292.
33. Cheh, M.A., Millonig, J.H., Roselli, L.M., Ming, X., Jacobsen, E., Kamdar, S., and Wagner, G.C. (2006). En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res. 1116, 166-176.
34. Cheng, L., Hattori, E., Nakajima, A., Woehrle, N.S., Opal, M.D., Zhang, C., Grennan, K., Dulawa, S.C., Tang, Y.P., Gershon, E.S., et al. (2014). Expression of the G72/G30 gene in transgenic mice induces behavioral changes. Mol. Psychiatry 19, 175-183.
35. Chomiak, T. and Hu, B. (2013). Alterations of neocortical development and maturation in autism: insight from valproic acid exposure and animal models of autism. Neurotoxicol. Teratol. 36, 57-66.
36. Chubb, J.E., Bradshaw, N.J., Soares, D.C., Porteous, D.J., and Millar, J.K. (2008). The DISC locus in psychiatric illness. Mol. Psychiatry 13, 36-64.
37. Clower, D.M., West, R.A., Lynch, J.C., and Strick, P.L. (2001). The inferior parietal lobule is the target of output from the superior colliculus, hippocampus, and cerebellum. J. Neurosci. 21, 6283-6291.
38. Clower, D.M., Dum, R.P., and Strick, P.L. (2005). Basal ganglia and cerebellar inputs to 'AIP'. Cereb. Cortex 7, 913-920.
39. Courchesne, E. (1991). Neuroanatomic imaging in autism. Pediatrics 87, 781-790.
40. DeLorey, T.M., Sahbaie, P., Hashemi, E., Homanics, G.E., and Clark, J.D. (2008). Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav. Brain Res. 5, 207-220.
41. Dietz, D., Vogel, M., Rubin, S., Moran, T., Carbone, K., and Pletnikov, M. (2004). Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: a multidisciplinary analysis. J. Neurovirol. 10, 267-277.
42. Doulazmi, M., Frédéric, F., Capone, F., Becher-André, M., Delhaye-Bouchaud, N., and Mariani, J. (2001). A comparative study of Purkinje cells in two ROR α gene mutant mice: stagger and ROR α(-/-). Dev. Brain Res. 127, 165-174.
43. Drews, E., Otte, D.M., and Zimmer, A. (2012). Involvement of the primate specific gene G72 in schizophrenia: From genetic studies to pathomechanisms. Neurosci. Biobehav. Rev. 37, 2410-2417.
44. Dufour-Rainfray, D., Vourc'h, P., Le Guisquet, A.M., Garreau, L., Ternant, D., Bodard, S., Jaumain, E., Gulhan, Z., Belzung, C., Andres, C.R., et al. (2010). Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci. Lett. 470, 55-59.
45. Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckarsater, H., et al. (2007). Mutations in the gene encoding the synaptic scaffolding protein Shank3 are associated autism spectrum disorders. Nat. Genet. 39, 25-27.
46. Dusart, I., Guenet, J.L., and Sotelo, C. (2006). Purkinje cell death: differences between developmental cell death and neurodegenerative death in mutant mice. Cerebellum 5, 163-173.
47. Eastwood, S.L., Cotter, D., and Harrison, P.J. (2001). Cerebellar synaptic protein expression in schizophrenia. Neuroscience 105, 219-229.
48. Eastwood, S.L., Law, A.J., Everall, I.P., and Harrison, P.J. (2003). The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol. Psychiatry 8, 148-155.
49. Ellegood, J., Pacey, L.K., Hampson, D.R., Lerch, J.P., and Henkelman, R.M. (2010). Anatomical phenotyping in a mouse model of fragile X syndrome with magnetic resonance imaging. Neuroimage 53, 1023-1029.
50. Ellegood, J., Markx, S., Lerch, J.P., Steadman, P.E., Genç, C., Provenzano, F., Kushner, S.A., Henkelman, R.M., Karayiorgou, M., and Gogos, J.A. (2013). Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Mol. Psychiatry 19, 99-107.
51. Ertan, G., Arulrajah, S., Tekes, A., Jordan, L., and Huisman, T.A. (2010). Cerebellar abnormality in children and young adults with tuberous sclerosis complex: MR and diffusion weighted imaging findings. J. Neuroradiol. 37, 231-238.
52. Evarts, E.V. and Thach, W.T. (1969). Motor mechanism of the CNS: cerebrocerebellar interrelations. Annu. Rev. Physiol. 31, 451-498.
53. Ey, E., Leblond, C.S., Bourgeron, T., and Pletnikov, M.V. (2011). Behavioral profiles of mouse models for autism spectrum disorders. Autism Res. 4, 5-16.
54. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., and Sidwell, R.W. (2008a). Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin. Schizophr. Res. 98, 163-177.
55. Fatemi, S.H., Reutiman, T.J., Folsom, T.D., Huang, H., Oishi, K., Mori, S., Smee, D.F., Pearce, D.A., Winter, C., Sohr, R., et al. (2008b). Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 99, 56-70.
56. Fatemi, S.H., Folsom, T.D., Reutiman, T.J., Abu-Odeh, D., Mori, S., Huang, H., and Oishi, K. (2009). Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice. Schizophr. Res. 112, 46-53.
57. Fatemi, S.H., Aldinger, K.A., Ashwood, P., Bauman, M.L., Blaha, C.D., Blatt, G.J., Chauhan, A., Chauhan, V., Dager, S.R., Dickson, P.E., et al. (2012). Consensus paper: pathological role of the cerebellum in autism. Cerebellum 11, 777-807.
58. Filiou, M.D., Teplytska, L., Otte, D.M., Zimmer, A., and Turck, C.W. (2012). Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model. J. Psychiatr. Res. 46, 1359-1365.
59. Fisher, S.E. and Scharff, C (2009). FOXP2 as a molecular window into speech and language. Trends Genet. 25, 166-177.
60. Fortier, M.E., Kent, S., Ashdown, H., Poole, S., Boksa, P., and Luheshi, G.N. (2004). The viral mimic, polyinosinic: polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, 759-766.
61. Fujita, E., Tanabe, Y., Imhof, B.A., Momoi, M.Y., and Momoi, T. (2012a). Cadm1-expressing synapses on Purkinje cell dendrites are involved in mouse ultrasonic vocalization activity. PLoS One 7, e30151.
62. Fujita, E., Tanabe, Y., Momoi, M.Y., and Momoi, T. (2012b). Cntnap2 expression in the cerebellum of Foxp2(R552H) mice, with a mutation related to speech-language disorder. Neurosci. Lett. 506, 277-280.
63. Fujita, E., Tanabe, Y., Imhof, B.A., Momoi, M.Y., and Momoi, T. (2012c). A complex of synaptic adhesion molecule CADM1, a molecule related to autism spectrum disorder, with MUPP1 in the cerebellum. J. Neurochem. 123, 886-894.
64. Gejman, P.V., Sanders, A.R., and Kendler, K.S. (2011). Genetics of schizophrenia: new findings and challenges. Annu. Rev. Genomics Hum. Genet. 12, 121-144.
65. Giza, J., Urbanski, M.J., Prestori, F., Bandyopadhyay, B., Yam, A., Friedrich, V., Kelley, K., D'Angelo, E., and Goldfarb, M. (2010). Behavioral and cerebellar transmission deficits in mice lacking the autism-linked gene islet brain-2. J. Neurosci. 30, 14805-14816.
66. Goines, P.E. and Ashwood, P. (2013). Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol. Teratol. 36, 67-81.
67. Goldowitz, D. and Koch, J. (1986). Performance of normal and neurological mutant mice on radial arm maze and active avoidance tasks. Behav. Neural. Biol. 46, 216-226.
68. Gomez, L., Wigg, K., Feng, Y., Kiss, E., Kapornai, K., Tamás, Z., Mayer, L., Baji, I., Daróczi, G., Benák, I., et al. (2009). G72/G30 (DAOA) and juvenile-onset mood disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150, 1007-10012.
69. Goodrich-Hunsaker, N.J., Wong, L.M., McLennan, Y., Tassone, F., Harvey, D., Rivera, S.M., and Simon, T.J. (2011). Adult female fragile X permutation carriers exhibit age-and CGG repeat length-related impairments on an attentionally based enumeration task. Front. Hum. Neurosci. 5, 63.
70. Goudarzi, S., Smith, L.J., Schütz, S., and Hafizi, S. (2013). Interaction of DISC1 with the PTB domain of Tensin2. Cell Mol. Life Sci. 70, 1663-1672.
71. Hamilton, B.A., Frankel, W.N., Kerrebrock, A.W., Hawkins, T.L., Fitzhugh, W., Kusumi, K., Russell, L.B., Mueller, K.L., van Berkel, V., Birren, B.W., et al. (1996). Disruption of the nuclear hormone receptor ROR α in staggerer mice. Nature. 379, 736-739.
72. Harkins, A.B. and Fox, A.P. (2002). Cell death in weaver mouse cerebellum. Cerebellum 1, 201-206.
73. Harvey, L. and Boksa, P. (2012). Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev. Neurobiol. 72, 1335-1348.
74. Herrup, K. and Mullen, R.J. (1979). Staggerer chimeras: intrinsic nature of Purkinje cell defects and implica tions for normal cerebellar development. Brain Res. 178, 443-457.
75. Herrup, K., Shojaeian-Zanjani, H., Panzini, L., Sunter, K., and Mariani, J. (1996). The numerical matching of source and target populations in the CNS: the inferior olive to Purkinje cell projection. Dev. Brain Res. 96, 28-35.
76. Iijima, S., Masaki, H., Wakayama, Y., Inoue, M., Jimi, T., Hara, H., Unaki, A., Oniki, H., Nakano, K., Hirayama, Y., et al. (2009). Immunohistochemical detection of dysbindin at the astroglial endfeet around the capillaries of mouse brain. J. Mol. Histol. 40, 117-1121.
77. Ingram, J.L., Peckham, S.M., Tisdale, B., and Rodier, P.M. (2000). Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22, 319-324.
78. Jaaro-Peled, H., Ayhan, Y., Pletnikov, M.V., and Sawa, A. (2010). Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr. Bull. 36, 301-313.
79. Jiang, Y.H. and Ehlers, M.D. (2013). Modeling autism by SHANK gene mutations in mice. Neuron 78, 8-27.
80. Jolly, S., Journiac, N., Vernet-der Garabedian, B., and Mariani, J. (2012). RORα, a key to the development and functioning of the brain. Cerebellum 11, 451-452.
81. Kamiya, A., Sedlak, T.W., and Pletnikov, M.V. (2012). DISC1 pathway in brain development: exploring therapeutic targets for major psychiatric disorders. Front Psychiatry 3, 25.
82. Kang, C. and Drayna, D. (2011). Genetics of speech and language disorders. Annu. Rev. Genomics Hum. Genet. 12, 145-164.
83. Kato, N., Sundmark, V.C., Van Middlesworth, L., Havlicek, V., and Friesen, H.G. (1982). Immunoreactive somatostatin and β-endorphin content in the brain of mature rats after neonatal exposure to propylthiouracil. Endocrinology 110, 1851-1855.
84. Kemper, T.L. and Bauman, M. (1998). Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 57, 645-652.
85. Kern, J.K. (2003). Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev. 25, 377-382.
86. Kim, J.E., Shin, M.S., Seo, T.B., Ji, E.S., Baek, S.S., Lee, S.J., Park, J.K., and Kim, C.J. (2013a). Treadmill exercise ameliorates motor disturbance through inhibition of apoptosis in the cerebellum of valproic acid-induced autistic rat pups. Mol. Med. Rep. 8, 327-334.
87. Kim, M., Yu, J.E., Lee, J.H., Chang, B.J., Song, C.S., Lee, B., Paik, D.J., and Nahm, S.S. (2013b). Comparative analyses of influenza virus receptor distribution in the human and mouse brains. J. Chem. Neuroanat. 52, 49-57.
88. Kimura, M., Toth, L.A., Agostini, H., Cady, A.B., Majde, J.A., and Krueger, J.M. (1994). Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am. J. Physiol. 267, 1596-1605.
89. Kinney, D.K., Yurgelun-Todd, D.A., and Woods, B.T. (1999). Neurologic signs of cerebellar and cortical sensory dysfunction in schizophrenics and their relatives. Schizophr. Res. 35, 99-104.
90. Kneeland, R.E. and Fatemi, S.H. (2013). Viral infection, inflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 42, 35-48.
91. Koekkoek, S.K., Yamaguchi, K., Milojkovic, B.A., Dortland, B.R., Ruigrok, T.J., Maex, R., De Graff, W., Smit, A.E., VanderWerf, F., Backker, C.E., et al. (2005). Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron 47, 339-352.
92. Konarski, J.Z., McIntyre, R.S., Grupp, L.A., and Kennedy, S.H. (2006). Is the cerebellum relevant in the circuitry of neuropsychiatric disorder? J. Psychiatry Neurosci. 30, 178-186.
93. Kuemerle, B., Zanjani, H., Joyner, A., and Herrup, K. (1997). Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. J. Neurosci. 17, 7881-7889.
94. Kuemerle, B., Gulden, F., Cherosky, N., Williams, E., and Herrup, K. (2007). The mouse engrailed genes: a window into autism. Brain Res. 176, 121-132.
95. Kvajo, M., Dhilla, A., Swor, D.E., Karayiorgou, M., and Gogos, J.A. (2008). Evidence implicating the candidate schizophrenia/ bipolar disorder susceptibility gene G72 in mitochondrial function. Mol. Psychiatry 13, 685-696.
96. Lalonde, R., Filali, M., Bensoula, A.N., and Lestienne, F. (1996). Sensorimotor learning in three cerebellar mutant mice. Neurobiol. Learn Mem. 65, 113-120.
97. Landis, D.M. and Sidman, R.L. (1978). Electron microscopic analysis of postnatal histogenesis in the cerebellar cortex of staggerer mutant mice. J. Comp. Neurol. 179, 831-863.
98. Lancaster, K., Dietz, D.M., Moran, T.H., and Pletnikov, M.V. (2007). Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav. Brain Res. 176, 141-148.
99. Laviola, G., Hannan, A.J., Macrì, S., Solinas, M., and Jaber, M. (2008). Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol. Dis. 31, 159-168.
100. Leiner, H.C. (2010). Solving the mystery of the human cerebellum. Neuropsychol. Rev. 20, 229-235.
101. Leiner, H.C., Leiner, A.L., and Dow, R.S. (1986). Does the cerebellum contribute to mental skills? Behav. Neurosci. 100, 443-454.
102. Lipkin, W.I., Briese, T., and Hornig, M. (2011). Borna disease virus - fact and fantasy. Virus Res. 162, 162-172.
103. Lungu, O., Barakat, M., Laventure, S., Debas, K., Proulx, S., Luck, D., and Stip, E. (2013). The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literature. Schizophr. Bull. 39, 797-806.
104. Ma, L., Liu, Y., Ky, B., Shughrue, P.J., Austin, C.P., and Morris, J.A. (2002). Cloning and characterization of Disc1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1). Genomics 80, 662-672.
105. Ma, T.M., Abazyan, S., Abazyan, B., Nomura, J., Yang, C., Seshadri, S., Sawa, A., Snyder, S.H., and Pletnkov, M.V. (2013). Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion. Mol. Psychiatry 18, 557-567.
106. Markram, K., Rinaldi, T., La Mendola, D., Sandi, C., and Markram, H. (2008). Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33, 901-912.
107. Martin, P. and Albers, M. (1995). Cerebellum and schizophrenia: a selective review. Schizophr. Bull. 21, 241-250.
108. Meyer, U. and Feldon, J. (2012). To poly(I: C) or not to poly(I: C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62, 1308-1321.
109. Meyer, U., Feldon, J., and Fatemi, S.H. (2009). In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 33, 1061-1079.
110. Michel, M., Schmidt, M.J., and Mirnics, K. (2012). Immune system gene dysregulation in autism and schizophrenia. Dev. Neurobiol. 72, 1277-1287.
111. Mihali, A., Subramani, S., and Kaunitz, G. (2012). Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev. Neurother. 12, 785-799.
112. Mukaetova-Ladinska, E., Hurt, J., Honer, W.G., Harrington, C.R., and Wischik, C.M. (2002). Loss of synaptic but not cytoskseletal proteins in the cerebellum of chronic schizophrenics. Neurosci. Lett. 317, 161-165.
113. Millar, J.K., Christie, S., Anderson, S., Lawson, D., Hsiao-Wei, L.D., Devon, R.S., Arveiler, B., Muir, W.J., Blackwood, D.H., and Porteous, D.J. (2001). Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol. Psychiatry 6, 173-178.
114. Millen, K.J., Wurst, W., Herrup, K., and Joyner, A.L. (1994). Abnormal embryonic cerebellar development and patterning of postnatal foliation in two mouse Engrailed-2 mutants. Development 120, 695-706.
115. Misslin, R., Cigrang, M., and Guastavino, J. (1986). Responses to novelty in staggerer mutant mice. Behav. Process. 12, 51-56.
116. Mychasiuk, R., Richards, S., Nakahashi, A., Kolb, B., and Gibb, R. (2012). Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. Dev. Neurosci. 34, 268-276.
117. Newbury, D.F. and Monaco, A.P. (2010). Genetic advances in the study of speech and language disorders. Neuron. 68, 309-320.
118. Nguyen, A., Rauch, T.A., Pfeifer, G.P., and Hu, V.W. (2010). Global methylation profiling of lymphoblastoid cell lines reveal epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J. 24, 3036-3051.
119. Olmos-Serrano, J.L., Corbin, J.G., and Burns, M.P. (2011). The GABAA receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev. Neurosci. 33, 395-403.
120. Otte, D.M., Bilkei-Gorzó, A., Filiou, M.D., Turck, C.W., Yilmaz, O., Holst, M.I., Schilling, K., Abou-Jamra, R., Schumacher, J., Benzel, I., et al. (2009). Behavioral changes in G72/G30 transgenic mice. Eur. Neuropsychopharmacol. 19, 339-348.
121. Otte, D.M., Sommersberg, B., Kudin, A., Guerrero, C., Albayram, O., Filiou, M.D., Frisch, P., Yilmaz, O., Drews, E., Turck, C.W., et al. (2011). N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology 36, 2233-2243.
122. Palmen, S.J., van Engeland, H., Hof, P.R., and Schmitz, C. (2004). Neuropathological findings in autism. Brain 127, 2572-2583.
123. Peça, J., Feliciano, C., Ting, J.T., Wang, W., Wells, M.F., Venkatraman, T.N., Lascola, C.D., Fu, Z., and Feng, G. (2011). Shank3 mutant mice display autistic-like behaviors and striatal dysfunction. Nature 472, 437-442.
124. Penagarikano, O. and Geschwind, D.H. (2012). What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol. Med. 18, 156-163.
125. Petit, E., Hérault, J., Martineau, J., Perrot, A., Barthélémy, C., Hameury, L., Sauvage, D., Lelord, G., and Muh, J.P. (1995). Association study with two markers of a human homeogene in infantile autism. J. Med. Genet. 32, 269-274.
126. Piontkewitz, Y., Arad, M., and Weiner, I. (2012). Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 62, 1273-1289.
127. Pletnikov, M.V., Moran, T.H., and Carbone, K.M. (2002). Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders. Front Biosci. 7, 593-607.
128. Pletnikov, M.V., Rubin, S.A., Moran, T.H., and Carbone, K.M. (2003). Exploring the cerebellum with a new tool: neonatal Borna disease virus (BDV) infection of the rat's brain. Cerebellum 2, 62-70.
129. Pletnikov, M.V. (2009). Inducible and conditional transgenic mouse models of schizophrenia. Prog. Brain Res. 179, 35-47.
130. Pratt, J., Winchester, C., Dawson, N., and Morris, B. (2012). Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat. Rev. Drug Discov. 11, 560-579.
131. Prevot, V., Rio, C., Cho, G.J., Lomniczi, A., Heger, S., Neville, C.M., Rosenthal, N.A., Ojeda, S.R., and Corfas, G. (2003). Normal female sexual development requires neuregulin-erbB receptor signaling in hypothalamic astrocytes. J. Neurosci. 23, 230-239.
132. Rapoport, J.L., Giedd, J.N., and Gogtay, N. (2012). Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 17, 1228-1238.
133. Reith, R.M., Way, S., McKenna, J. 3rd, Haines, K., and Gambello, M.J. (2011). Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration. Neurobiol. Dis. 43, 113-122.
134. Reith, R.M., McKenna, J., Wu, H., Hashmi, S.S., Cho, S.H., Dash, P.K., and Gambello, M.J. (2013). Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclero sis complex. Neurobiol. Dis. 51, 93-103.
135. Rodier, P.M., Ingram, J.L., Tisdale, B., and Croog, V.J. (1997). Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 11, 417-422.
136. Rodriguez-Murillo, L., Gogos, J.A., and Karayiorgou, M. (2012). The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu. Rev. Med. 63, 63-80.
137. Roffler-Tarlov, S. and Herrup, K. (1981). Quantitative examination of the deep cerebellar nuclei in the staggerer mutant mouse. Brain Res. 215, 49-59.
138. Rogers, S.J., Wehner, D.E., and Hagerman, R. (2001). The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J. Dev Behav Pediatr. 22, 409-417.
139. Rogers, T.D., McKimm, E., Dickson, P.E., Goldowitz, D., Blaha, C.D., and Mittleman, G. (2013). Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research. Front Syst. Neurosci. 7, 15.
140. Rott, R., Herzog, S., Fleischer, B., Winokur, A., Amsterdam, J., Dyson, W., and Koprowski, H. (1985). Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755-756.
141. Roullet, F.I., Lai, J.K., and Foster, J.A. (2013). In utero exposure to valproic acid and autism - a current review of clinical and animal studies. Neurotoxicol. Teratol. 36, 47-56.
142. Sadamatsu, M. and Watanabe, K. (2005). Is a neonatal hypothyroid rat useful as an animal model of autism? Neurosci. Res. 52, 28.
143. Sadamatsu, M., Kanai, H., Xu, X., Liu, Y., and Kato, N. (2006). Review of animal models for autism: implication of thyroid hormone. Congenit. Anom. 46, 1-9.
144. Sandhya, T., Sowjanya, J., and Veeresh, B. (2012). Bacopa monniera (L.) Wettest ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem. Res. 5, 1121-1131.
145. Schmahmann, J.D. (1991). An emerging concept. The cerebellar contribution to higher function. Arch. Neurol. 48, 1178-1187.
146. Schneider, T. and Przewlocki, R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30, 80-89.
147. Schneider, T., Turczak, J., and Przewlocki, R. (2006). Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31, 36-46.
148. Schneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., and Przewlocki, R. (2008). Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33, 728-740.
149. Schurov, I.L., Handford, E.J., Brandon, N.J., and Whiting, P.J. (2004). Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 9, 100-110.
150. Schwarz, J.M. and Bilbo, S.D. (2012). Sex, glia, and development: interactions in health and disease. Horm. Behav. 62, 243-253.
151. Sen, B., Singh, A.S., Sinha, S., Chatterjee, A., Ahmed, S., Ghosh, S., and Usha, R. (2010). Family-based studies indicate association of Engrailed 2 gene with autism in an Indian population. Genes Brain Behav. 9, 248-255.
152. Shi, J., Badner, J.A., Gershon, E.S., and Liu, C. (2008). Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr. Res. 98, 89-97.
153. Shi, L., Smith, S.E., Malkova, N., Tse, D., Su, Y., and Patterson, P.H. (2009). Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 23, 116-123.
154. Shu, W., Cho, J.Y., Jiang, Y., Zhang, M., Weisz, D., Elder, G.A., Schmeidler, J., De Gasperi, R., Sosa, M.A., Rabidou, D., et al. (2005). Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc. Natl. Acad. Sci. USA 102, 9643-9648.
155. Sierra-Honigmann, A.M., Carbone, K.M., and Yolken, R.H. (1995). Polymerase chain reaction (PCR) search for viral nucleic acid sequences in schizophrenia. Br. J. Psychiatry 166, 55-60.
156. Sillitoe, R.V., Stephen, D., Lao, Z., and Joyner, A.L. (2008). Engrailed homeobox genes determine the organization of Purkinje cell sagittal stripe gene expression in the adult cerebellum. J. Neurosci. 28, 12150-12162.
157. Snider, S.R. (1982). Cerebellar pathology in schizophrenia - cause or consequence? Neurosci. Biobehav. Rev. 6, 47-53.
158. Stanton, M.E., Peloso, E., Brown, K.L., and Rodier, P. (2007). Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism. Behav. Brain Res. 176, 133-140.
159. Stark, K.L., Xu, B., Bagchi, A., Lai, W.S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A.A., Karayiorgou, M., et al. (2008). Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751-760.
160. St Clair, D., Blackwood, D., Muir, W., Carothers, A. Walker, M., Spowart, G., Gosden, C., and Evans, H.J. (1990). Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13-16.
161. Sullivan, P.F., Daly, M.J., and O'Donovan, M. (2012). Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet. 13, 537-551.
162. Sullivan, P.F. (2013). Questions about DISC1 as a genetic risk factor for schizophrenia. Mol. Psychiatry 18, 1050-1052.
163. Supprian, T., Ulmar, G., Bauer, M., Schüler, M., Püschel, K., Retz-Junginger, P., Schmitt, H.P., and Heinsen, H. (2000). Cerebellar vermis area in schizophrenic patients - a post-mortem study. Schizophr. Res. 16, 19-28.
164. Taieb, O., Baleyte, J.M., Mazet, P., and Fillet, A.M. (2001). Borna disease virus and psychiatry. Eur. Psychiatry 16, 3-10.
165. Takuma, K., Ago, Y., and Matsuda, T. (2011). Preventive effects of an enriched environment on rodent psychiatric disorder models. J. Pharmacol. Sci. 117, 71-76.
166. Thomson, P.A., Malavasi, E.L., Grünewald, E., Soares, D.C., Borkowska, M., and Millar, J.K. (2013). DISC1 genetics, biology and psychiatric illness. Front Biol. (Beijing). 8, 1-31.
167. Triantafilou, M. and Triantafilou, K. (2002). Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23, 301-304.
168. Tsai, P.T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A.R., Leech, J.M., Steinberg, J, Crawley, J.N., Regehr, W.G., and Sahin, M. (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488, 647-651.
169. Tsiouris, J.A. and Brown, W.T. (2004). Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy. CNS Drugs 18, 687-703.
170. Van Middlesworth, L. and Norris, C.H. (1980). Audiogenic seizures and cochlear damage in rats after perinatal antithyroid treatment. Endocrinology 106, 1686-1690.
171. Verhoeven, J.S., De Cock, P., Lagae, L., and Sunaert, S. (2010). Neuroimaging of autism. Neuroradiology 52, 3-14.
172. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a break point cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
173. Villanueva, R. (2012). The cerebellum and neuropsychiatric disorders. Psychiatry Res. 198, 527-532.
174. Vogel, M.W., Caston, J., Yuzaki, M., and Mariani, J. (2007). The Lurcher mouse: fresh insights from an old mutant. Brain Res. 1140, 4-18.
175. Waltrip, R.W. 2nd, Buchanan, R.W., Summerfelt, A., Breier, A., Carpenter, W.T. Jr, Bryant, N.L., Rubin, S.A., and Carbone, K.M. (1995). Borna disease virus and schizophrenia. Psychiatry Res. 56, 33-44.
176. Wu, W., Peden, D., and Diaz-Sanchez, D. (2012). Role of GSTM1 in resistance to lung inflammation. Free Radic. Biol. Med. 53, 721-729.
177. Xu, M., Sajdel-Sulkowska, E.M., Iwasaki, T., and Koibuchi, N. (2013a). Aberrant cerebellar neurotrophin-3 expression induced by lipopolysaccharide exposure during brain development. Cerebellum 12, 316-318.
178. Xu, M., Sulkowski, Z.L., Parekh, P., Khan, A., Chen, T., Midha, S., Iwasaki, T., Shimokawa, N., Koibuchi, N., Zavacki, A.M., et al. (2013b). Effects of perinatal lipopolysaccharide (LPS) exposure on the developing rat brain; modeling the effect of maternal infection on the developing human CNS. Cerebellum 12, 572-586.
179. Yasuda, S., Ishida, N., Higashiyama, A., Morinobu, S., and Kato, N. (2000). Characterization of audiogenic-like seizures in naive rats evoked by activation of AMPA and NMDA receptors in the inferior colliculus. Exp. Neurol. 164, 396-406.
180. Yeganeh-Doost, P., Gruber, O., Falkai, P., and Schmitt, A. (2011). The role of the cerebellum in schizophrenia: from cognition to molecular pathways. Clinics (Sao Paulo). 66(Suppl 1), 71-77.
181. Yochum, C.L., Dowling, P., Reuhl, K.R., Wagner, G.C., and Ming, X. (2008). VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res. 1203, 126-132.
182. Yochum, C.L., Bhattacharya, P., Patti, L., Mirochnitchenko, O., and Wagner, G.C. (2010). Animal model of autism using GSTM1 knockout mice and early postnatal sodium valproate treatment. Behav. Brain Res. 210, 202-210.
183. Yuskaitis, C.J., Beurel, E., and Jope, R.S. (2010). Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochem. Biophys. Acta 1802, 1006-1012.
184. Zariwala, H.A., Madisen, L., Ahrens, K.F., Bernard, A., Lein, E.S., Jones, A.R., and Zeng, H. (2011). Visual tuning properties of genetically identified layer 2/3 neuronal types in the primary visual cortex of cre-transgenic mice. Front Syst. Neurosci. 4, 162.